REGENERON PHARMACEUTICALS, INC.【REGN】バランスシート
時価総額
$860億
PER
医薬品の研究開発と商業化の大手。抗体技術と主力薬EYLEAを展開。2022年5月のCheckmate買収、2023年9月のDecibel買収、2024年4月の2seventybioの権利取得。米国・欧州中心に展開。
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| 現金同等物 | 113 | 484 | 230 | 536 | 649 | 809 | 535 | 813 | 1,480 | 1,630 | 2,207 | 2,898 | 3,119 | 2,738 | 2,489 |
| 有価証券 | 137 | 43 | 78 | 158 | 252 | 236 | 503 | 597 | 1,342 | 1,597 | 1,393 | 2,809 | 4,636 | 8,115 | 6,524 |
| 現金 + 有価証券 | 249 | 527 | 308 | 694 | 900 | 1,045 | 1,039 | 1,410 | 2,822 | 3,227 | 3,601 | 5,707 | 7,756 | 10,853 | 9,013 |
| 売掛金 | 14 | 28 | 593 | 787 | 739 | 1,152 | 1,343 | 1,539 | 1,724 | 2,100 | 3,112 | 6,037 | 5,329 | 5,667 | 6,212 |
| 商品及び製品 | - | - | - | 70 | 129 | 239 | 399 | 726 | 1,151 | 1,416 | 1,917 | 1,951 | 2,402 | 2,581 | 3,087 |
| 流動資産合計 | 358 | 653 | 1,206 | 1,797 | 2,167 | 2,915 | 3,180 | 4,335 | 6,448 | 7,689 | 9,779 | 14,015 | 15,884 | 19,479 | 18,661 |
| 有形固定資産 | 347 | 368 | 380 | 527 | 974 | 1,594 | 2,083 | 2,359 | 2,576 | - | - | - | - | - | - |
| 投資有価証券 | 370 | 276 | 271 | 390 | 460 | 632 | 864 | 1,486 | 1,755 | 3,257 | 3,136 | 6,838 | 6,592 | 5,397 | 8,900 |
| 固定資産合計 | 732 | 671 | 874 | 1,154 | 1,704 | 2,694 | 3,793 | 4,429 | 5,287 | 7,116 | 7,384 | 11,420 | 13,330 | 13,601 | 19,099 |
| 総資産 | 1,089 | 1,324 | 2,080 | 2,951 | 3,872 | 5,609 | 6,973 | 8,764 | 11,735 | 14,805 | 17,163 | 25,435 | 29,215 | 33,080 | 37,759 |
| 買掛金 | - | - | - | - | - | - | - | - | 218 | 418 | 476 | 564 | 589 | 607 | 790 |
| 流動負債合計 | 109 | 148 | 164 | 299 | 655 | 811 | 1,241 | 1,135 | 1,443 | 2,097 | 2,697 | 3,933 | 3,141 | 3,423 | 3,944 |
| 長期借入金 | - | - | - | - | - | - | - | - | - | - | 1,979 | 1,980 | 1,981 | 1,983 | 1,984 |
| 固定負債合計 | 453 | 690 | 672 | 700 | 675 | 1,143 | 1,283 | 1,485 | 1,534 | 1,619 | 3,441 | 2,734 | 3,409 | 3,684 | 4,462 |
| 総負債 | 562 | 838 | 835 | 999 | 1,330 | 1,954 | 2,524 | 2,620 | 2,977 | 3,716 | 6,138 | 6,666 | 6,551 | 7,107 | 8,406 |
| 資本金及び資本剰余金 | 1,576 | 1,755 | 1,764 | 2,046 | 2,451 | 3,100 | 3,030 | 3,513 | 3,912 | 4,429 | 6,716 | 8,088 | 9,949 | 11,354 | 12,856 |
| 利益剰余金 | -1,046 | -1,267 | -517 | -93 | 255 | 853 | 1,748 | 2,947 | 5,254 | 7,380 | 10,893 | 18,968 | 23,307 | 27,260 | 31,673 |
| 株主資本 | 528 | 486 | 1,245 | 1,952 | 2,542 | 3,655 | 4,449 | 6,144 | 8,757 | 11,090 | 11,025 | 18,769 | 22,664 | 25,973 | 29,354 |
| 有利子負債合計 | - | - | - | - | - | - | - | - | - | - | 1,979 | 1,980 | 1,981 | 1,983 | 1,984 |
| 純有利子負債 | - | - | - | - | - | - | - | - | - | - | -1,622 | -3,727 | -5,774 | -8,870 | -7,029 |
| DEレシオ（％） | - | - | - | - | - | - | - | - | - | - | 17.9 | 10.5 | 8.7 | 7.6 | 6.8 |
| 運転資本 | - | - | - | - | - | - | - | - |